SEC Form 4 · accession 0001127602-18-010113
Elevance Health, Inc. · ELV
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Craig E Samitt
Officer — EVP & Chief Clinical Officer
Period of report
Mar 1, 2018
Accepted (ET)
Mar 5, 2018 · 4:51 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001156039
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Mar 1, 2018 | F | 677 | $232.04 | D | 8,317 | D | |
| Common StockF2 | Mar 1, 2018 | A | 2,694 | $0.00 | A | 11,011 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (Right to Buy)F3 | $232.04 | Mar 1, 2018 | A | 11,354 | A | — | Mar 1, 2028 | Common Stock | 11,354 | 11,354 | D |
Explanation of responses
- F1PAYMENT OF TAX LIABILITY BY WITHHOLDING STOCK INCIDENT TO THE VESTING OF PREVIOUSLY GRANTED RESTRICTED STOCK.
- F2Represents restricted share units. Restrictions lapse as follows: 898 shares each on 3/1/2019, 3/1/2020 and 3/1/2021.
- F3The option represents a right to purchase a total of 11,354 shares, and is exercisable in six semi-annual installments, with four installments of 1,892 shares each and two installments of 1,893 shares each, beginning on September 1, 2018, which is the six-month anniversary of the option grant date.